Stock Taper 
| DATE | TYPE | RATIO |
|---|---|---|
| 2015-04-27 | Reverse | 1:10 |
| 2007-11-26 | Reverse | 1:136 |
| 2007-07-23 | Reverse | 1:136 |
Astrana Health, Inc. is a physician-centric, technology-driven healthcare management company in the U.S. offering coordinated, value-based care through its integrated platform to patients, providers, and payers across multiple segments.
A technology-driven platform offering healthcare providers AI analytics, care management, and administrative tools to succeed in value-based care, improve patient outcomes, and reduce costs.
Astrana Health closed its acquisition of Prospect Health on July 1, 2025, for a total of $708 million. This strategic acquisition significantly expanded Astrana's presence into California, Texas, Arizona, and Rhode Island, adding approximately 610,000 members and deepening its capabilities in value-based care.
In a major strategic move to accelerate its growth and capabilities in value-based care, Astrana Health closed its acquisition of Prospect Health. This transaction substantially increases Astrana's scale, adding approximately 600,000 members and over 11,000 providers to its network across multiple states.
Astrana Health (NASDAQ: ASTH - Get Free Report) and Tenet Healthcare (NYSE: THC - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Risk and Volatility Astrana Health has a beta
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
LOS ANGELES--(BUSINESS WIRE)---- $ASTH--ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
 LFST | $12.04 | COMPARE |
 ACHC | $28.68 | COMPARE |
 AVAH | $12.24 | COMPARE |
 MD | $26.19 | COMPARE |
 OMCL | $34.08 | COMPARE |
 HCSG | $21.11 | COMPARE |
 USPH | $83.98 | COMPARE |
 MNKD | $3.75 | COMPARE |
